<DOC>
	<DOCNO>NCT02231502</DOCNO>
	<brief_summary>The purpose study establish extent innovation food production technique may facilitate retention bioactive compound healthy individual . The study single-blinded ( outcome assessor ) , cross-over design ; wherein , plasma concentration urinary excretion level range bioactive compound assess 24 hour period follow intake either vegetable base convenience food , minimally process meal contain vegetable material . To , 20 healthy volunteer attend two assessment day ( follow-up assessment +24hr ) provide blood urine sample , collect biologically relevant time 24 hour period . In cross-over study , meal eat separate day , wash-out period least 1 week assessment .</brief_summary>
	<brief_title>Innovation Food Production Techniques Improve Bioactive Content</brief_title>
	<detailed_description />
	<criteria>Men woman â‰¥ 18 year old Successful biochemical , haematological urinalysis assessment screen Current smoker , exsmokers cease &lt; 3 month ago Pregnant woman , currently breast feed Subjects exist significant past medical history medical condition likely affect study measure i.e . diabetes , hepatic , renal , digestive cancer ( exclude Basalcell carcinoma ) judge study clinical advisor . Those unprepared adhere dietary restriction 3d preceding assessment day . Parallel participation another research project involve dietary intervention and/or sample biological fluids/material . Those therapeutic diet experience substantial weight loss ( judged clinical advisor ) within 3 month screen Taking dietary supplement contain flavonoid , isothiocyanate carotene ( include multivitamin ) ( unwilling cease intake , 1 month precede trial ) unwilling maintain exist intake supplement . Prescribed medication likely affect ADME ( absorption , distribution , metabolism , excretion ) ; medication assess suitability clinical advisor . Clinical advisor judge : abnormal biochemical , haematological urinary result measurement consider counter indicative study : include kidney liver function , fast glucose ( especially indicative diabetes ) , lipid abnormality , full blood count .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Bioavailability healthy individual</keyword>
</DOC>